CRH (CRH) Q3 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 TU earnings summary
8 Jul, 2026Executive summary
Delivered robust Q3 2024 results with 4% revenue growth to $10.5bn, 12% Adjusted EBITDA growth to $2.5bn, and 10% EPS growth, despite adverse weather and inflationary pressures.
Reaffirmed full-year guidance and positive outlook for 2025, supported by strong infrastructure and non-residential demand.
Significant portfolio activity with $4.6bn invested in 35 acquisitions, including major deals in Texas and Australia, and $1.2bn in divestitures year-to-date.
Ongoing share buyback program ($1.2bn YTD) and new $0.3bn tranche; quarterly dividend of $0.35/share (+5% annualized) declared.
CEO transition announced, with Albert Manifold retiring and Jim Mintern appointed as CEO.
Financial highlights
Q3 revenues reached $10.5bn (+4% YoY); 9M revenues at $26.7bn (+2%).
Q3 Adjusted EBITDA was $2.5bn (+12% YoY); 9M Adjusted EBITDA at $5.2bn (+12%).
Adjusted EBITDA margin expanded to 23.3% in Q3 (+170bps); 9M margin at 19.3% (+180bps).
Q3 EPS was $1.99 (+10% YoY); 9M EPS at $4.03 (+20% YoY).
Net income guidance for full year: $3.78–$3.85bn; EPS: $5.45–$5.55.
Outlook and guidance
Full-year Adjusted EBITDA expected between $6.87bn and $6.97bn, reaffirming guidance midpoint.
Capital expenditure guidance for 2024 raised to $2.4bn–$2.6bn.
Anticipates robust infrastructure demand in the U.S. and internationally, with gradual improvement in residential new-build activity in H2 2025 as interest rates normalize.
Positive pricing momentum and disciplined commercial management expected to continue.
Potential Q4 impairment in the range of $0.3–$0.4bn not reflected in current guidance.
Latest events from CRH
- Q2 saw 8% net income growth, 12% EBITDA rise, margin expansion, and raised FY24 guidance.CRH
H1 20248 Jul 2026 - $8.5B acquisition expands infrastructure leadership and targets $175M in synergies by year three.CRH
M&A announcement22 Jun 2026 - Q1 2026 saw 9% revenue growth, higher EBITDA, and reaffirmed guidance despite a wider net loss.CRH
Q1 202630 Apr 2026 - Record 2025 financials, double-digit EBITDA growth, and strong 2026 outlook on infrastructure demand.CRH
Q4 202511 Apr 2026 - Definitive proxy statement filed for shareholder voting under SEC regulations.CRH
Proxy filing27 Mar 2026 - Record financials, capital structure simplification, and strong governance drive 2026 agenda.CRH
Proxy filing27 Mar 2026 - Record financials, capital structure simplification, and key governance proposals for 2026 AGM.CRH
Proxy Filing13 Mar 2026 - Delisting and preference share cancellations aim to simplify capital structure and cut costs.CRH
Proxy Filing13 Mar 2026 - Double-digit profit growth and margin expansion achieved, with strong 2025 outlook.CRH
H2 20247 Jan 2026